Adverse events60

Each adverse event the trial posted, group by group: the participants affected out of those at risk.

41 to 60 of 60

Download this page as JSON

Type	Event	Organ system	Group	Affected	At risk
other	Vomiting	Gastrointestinal disorders	Sotagliflozin 200 mg	0	10
other	Vomiting	Gastrointestinal disorders	Sotagliflozin 400 mg	1	11
other	Dermatitis allergic	Skin and subcutaneous tissue disorders	Placebo	0	10
other	Dermatitis allergic	Skin and subcutaneous tissue disorders	Sotagliflozin 200 mg	0	10
other	Dermatitis allergic	Skin and subcutaneous tissue disorders	Sotagliflozin 400 mg	1	11
other	Fluid intake reduced	Metabolism and nutrition disorders	Placebo	0	10
other	Fluid intake reduced	Metabolism and nutrition disorders	Sotagliflozin 200 mg	1	10
other	Fluid intake reduced	Metabolism and nutrition disorders	Sotagliflozin 400 mg	0	11
other	Hyperkalaemia	Metabolism and nutrition disorders	Placebo	0	10
other	Hyperkalaemia	Metabolism and nutrition disorders	Sotagliflozin 200 mg	0	10
other	Hyperkalaemia	Metabolism and nutrition disorders	Sotagliflozin 400 mg	1	11
other	Hypoglycaemia	Metabolism and nutrition disorders	Placebo	0	10
other	Hypoglycaemia	Metabolism and nutrition disorders	Sotagliflozin 200 mg	0	10
other	Hypoglycaemia	Metabolism and nutrition disorders	Sotagliflozin 400 mg	1	11
other	Type 2 diabetes mellitus	Metabolism and nutrition disorders	Placebo	0	10
other	Type 2 diabetes mellitus	Metabolism and nutrition disorders	Sotagliflozin 200 mg	0	10
other	Type 2 diabetes mellitus	Metabolism and nutrition disorders	Sotagliflozin 400 mg	1	11
serious	Upper respiratory tract infection	Infections and infestations	Placebo	1	10
serious	Upper respiratory tract infection	Infections and infestations	Sotagliflozin 200 mg	0	10
serious	Upper respiratory tract infection	Infections and infestations	Sotagliflozin 400 mg	0	11

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT03292653/events?page=3

API reference For AI assistants

Adverse events60

Sources 3

Read this list from software.